| [1] |
Marshall JD, Maffei P, Beck S, et al. Clinical utility gene card for: Alström Syndrome - update 2013[J]. Eur J Hum Genet,2013 Nov; 21(11). doi: 10.1038/ejhg.2013.61.
|
| [2] |
Wang C, Luo X, Wang Y, et al. Novel Mutations of the ALMS1 Gene in Patients with Alström Syndrome[J]. Intern Med, 2021, 60(23):3721-3728. doi: 10.2169/internalmedicine.6467-20.
|
| [3] |
Tahani N, Maffei P, Dollfus H, et al. Consensus clinical management guidelines for Alström syndrome[J]. Orphanet J Rare Dis, 2020, 15(1):253. doi: 10.1186/s13023-020-01468-8.
pmid: 32958032
|
| [4] |
王云芳, 万小艳, 牛瑞兰, 等. Alstrom综合征两例报道[J]. 中国糖尿病杂志, 2023, 31(2):139-144. doi: 10.3969/j.issn.1006-6187.2023.02.012.
|
| [5] |
Choudhury AR, Munonye I, Sanu KP, et al. A review of Alström syndrome: a rare monogenic ciliopathy[J]. Intractable Rare Dis Res, 2021, 10(4):257-262. doi: 10.5582/irdr.2021.01113.
|
| [6] |
Waldman M, Han JC, Reyes-Capo DP, et al. Alström syndrome: Renal findings in correlation with obesity, insulin resistance, dyslipidemia and cardiomyopathy in 38 patients prospectively evaluated at the NIH clinical center[J]. Mol Genet Metab, 2018, 125(1/2):181-191. doi: 10.1016/j.ymgme.2018.07.010.
|
| [7] |
Sanyoura M, Woudstra C, Halaby G, et al. A novel ALMS1 splice mutation in a non-obese juvenile-onset insulin-dependent syndromic diabetic patient[J]. Eur J Hum Genet, 2014, 22(1):140-143. doi: 10.1038/ejhg.2013.87.
pmid: 23652376
|
| [8] |
Nerakh G, Ranganath P. Alström Syndrome Presenting as Isolated Dilated Cardiomyopathy[J]. Indian J Pediatr, 2019, 86(3):296-298. doi: 10.1007/s12098-018-2807-9.
pmid: 30484169
|
| [9] |
Shenje LT, Andersen P, Halushka MK, et al. Mutations in Alström protein impair terminal differentiation of cardiomyocytes[J]. Nat Commun, 2014,5:3416. doi: 10.1038/ncomms4416.
|
| [10] |
Jiang P, Xiao L, Guo Y, et al. Novel mutations of the Alström syndrome 1 gene in an infant with dilated cardiomyopathy: A case report[J]. World J Clin Cases, 2022, 10(7):2330-2335. doi: 10.12998/wjcc.v10.i7.2330.
pmid: 35321175
|
| [11] |
Marshall JD, Bronson RT, Collin GB, et al. New Alström syndrome phenotypes based on the evaluation of 182 cases[J]. Arch Intern Med, 2005, 165(6):675-683. doi: 10.1001/archinte.165.6.675.
pmid: 15795345
|
| [12] |
Hearn T. ALMS1 and Alström syndrome: a recessive form of metabolic, neurosensory and cardiac deficits[J]. J Mol Med(Berl), 2019, 97(1):1-17. doi: 10.1007/s00109-018-1714-x.
|
| [13] |
Burgy O, Königshoff M. The WNT signaling pathways in wound healing and fibrosis[J]. Matrix Biol, 2018, 68/69:67-80. doi: 10.1016/j.matbio.2018.03.017.
|
| [14] |
牛兆霞, 杨美荣, 陈桂芝. Alstrom综合征的诊治进展[J]. 青岛医药卫生, 2007, 39(6):442-444. doi: 10.3969/j.issn.1006-5571.2007.06.026.
|
| [15] |
张倩文. Alstrom综合征的发病机制及诊治进展[J]. 国际儿科学杂志, 2020, 47(1):59-62. doi: 10.3760/cma.j.issn.1673-4408.2020.01.015.
|
| [16] |
Han JC, Reyes-Capo DP, Liu CY, et al. Comprehensive Endocrine-Metabolic Evaluation of Patients With Alström Syndrome Compared With BMI-Matched Controls[J]. J Clin Endocrinol Metab, 2018, 103(7):2707-2719. doi: 10.1210/jc.2018-00496.
pmid: 29718281
|